Zobrazeno 1 - 10
of 409
pro vyhledávání: '"Yechezkel Barenholz"'
Publikováno v:
Progress in Orthodontics, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background The prevailing paradigm posits orthodontic tooth movement (OTM) as primarily a localized inflammatory process. In this study, we endeavor to elucidate the potential ramifications of mechanical force on systemic immunity, employing
Externí odkaz:
https://doaj.org/article/bc9f408f3f654c4baa147fa3f309a2d2
Autor:
Yael Shilo-Benjamini, Eran Lavy, Nadav Yair, Joshua Milgram, Daniel Zilbersheid, Atara Hod, Dinorah Barasch, Wiessam Abu Ahmad, Ahuva Cern, Yechezkel Barenholz
Publikováno v:
Frontiers in Veterinary Science, Vol 10 (2023)
IntroductionOsteoarthritis is a common disease in dogs resulting in chronic pain and decreased wellbeing. Common analgesics such as non-steroidal anti-inflammatories may fail to control pain and can produce major adverse effects. Study objectives wer
Externí odkaz:
https://doaj.org/article/1eeec5d59c1448a0a52485e638dde70e
Autor:
Noy Pinto, Yehuda Klein, Eilon David, David Polak, Daniel Steinberg, Gilad Mizrahi, Yasmin Khoury, Yechezkel Barenholz, Stella Chaushu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionAllografts are the most common bone grafts for repairing osseous defects. However, their use is associated with an increased risk for infections, donor disease transmission and osteointegration deficiency. Resolvin D1 (RvD1) is an endogen
Externí odkaz:
https://doaj.org/article/25f04266b60c4e5cb2648596a773822b
Autor:
Yehuda Klein, Offir Levin-Talmor, Jaime Garber Berkstein, Sharon Wald, Yaron Meirow, Avi Maimon, Avi Leibovich, Yechezkel Barenholz, David Polak, Stella Chaushu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The study aimed to investigate the role of RvD1 in acute and prolonged sterile inflammation and bone remodeling. A mouse model of sterile inflammation that involves bone resorption was used to examine endogenous RvD1 kinetics during inflammation. App
Externí odkaz:
https://doaj.org/article/6d7187d0b0394bacae0e27f6dcc6772e
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 12, Pp 3146-3154 (2020)
Traditional non-living vaccines are often least effective in the populations that need them most, such as neonates and elderly adults. Vaccine adjuvants are one approach to boost the immunogenicity of antigens in populations with reduced immunity. Id
Externí odkaz:
https://doaj.org/article/e6a01a41afe948f18b8efd49248aaccc
Autor:
Yael Shilo-Benjamini, Ahuva Cern, Daniel Zilbersheid, Atara Hod, Eran Lavy, Dinorah Barasch, Yechezkel Barenholz
Publikováno v:
Frontiers in Veterinary Science, Vol 9 (2022)
A 14-year-old intact mixed breed dog (26 kg) was submitted for a novel cannabidiol (CBD) analgesic treatment. The dog was cachectic and had a testicular neoplasia, hip and elbow osteoarthritis and severe cervical pain. Analgesic treatment included ca
Externí odkaz:
https://doaj.org/article/490c357671bb4452ac25c2722c94c4d9
Autor:
Liza Silverman, Yechezkel Barenholz
Publikováno v:
Precision Nanomedicine, Vol 3, Iss 4 (2020)
Our previous studies demonstrate that ammonia induces doxorubicin release from Doxil® in a concentration-dependent manner. Because ammonia that results from glutaminolysis is continu-ously generated in tumors at high enough concentration to induce d
Externí odkaz:
https://doaj.org/article/de32542c12f14bc89070980327b55546
Autor:
Xiaohui Wei, Dima Shamrakov, Sioma Nudelman, Sivan Peretz-Damari, Einat Nativ-Roth, Oren Regev, Yechezkel Barenholz
Publikováno v:
ACS Omega, Vol 3, Iss 3, Pp 2508-2517 (2018)
Externí odkaz:
https://doaj.org/article/f31b0555265a4886b291e340282c5578
Autor:
Emma Grabarnick (Portnoy), Alexander V. Andriyanov, Hadas Han, Sara Eyal, Yechezkel Barenholz
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 2181 (2021)
Multidrug resistance (MDR) of cancer cells remains a major obstacle to favorable outcomes of treatment with many drugs, including doxorubicin. Most of the clinical trials failed to demonstrate the benefit of the drug efflux transporter P-glycoprotein
Externí odkaz:
https://doaj.org/article/eabeaa5a778f413688ce59b3a374319b
Autor:
Ahuva Cern, Yaelle Bavli, Atara Hod, Daniel Zilbersheid, Shazad Mushtaq, Ayelet Michael-Gayego, Dinorah Barasch, Yael Feinstein Rotkopf, Allon E. Moses, David M. Livermore, Yechezkel Barenholz
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 2186 (2021)
Antibiotic resistance is a global health threat. There are a few antibiotics under development, and even fewer with new modes of action and no cross-resistance to established antibiotics. Accordingly, reformulation of old antibiotics to overcome resi
Externí odkaz:
https://doaj.org/article/88f8dd726fd14c7a8535af5349bf0ad5